Sleep and Circadian Rhythm + Memory Support for Sleep Disorders
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Memory Support Intervention (MSI) for sleep disorders?
Research shows that similar treatments, like the Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C), have been effective in improving sleep and mental health outcomes. Additionally, interventions targeting sleep in older adults with mild cognitive impairment have shown improvements in sleep quality, which is linked to better cognitive health.12345
Is the Sleep and Circadian Rhythm + Memory Support treatment safe for humans?
How is the Memory Support Intervention treatment different from other treatments for sleep disorders?
The Memory Support Intervention is unique because it targets both sleep and circadian rhythm disruptions, which are linked to memory issues, especially in older adults. This approach is novel as it aims to restore regular circadian rhythms, potentially preventing or slowing neurodegenerative diseases and improving cognitive function.69101112
What is the purpose of this trial?
Mental illness is often chronic, severe, and difficult to treat. Though there has been significant progress towards establishing effective and efficient interventions for psychological health problems, many individuals do not gain lasting benefits from these treatments. The Memory Support Intervention (MSI) was developed utilizing existing findings from the cognitive science literature to improve treatment outcomes. In this study, the investigators aim to conduct an open trial that includes individuals 50 years and older to assess if a novel version of the Memory Support Intervention improves sleep and circadian functioning, reduces functional impairment, and improves patient memory for treatment.
Research Team
Allison G Harvey, PhD
Principal Investigator
University of California, Berkeley
Eligibility Criteria
This trial is for individuals aged 50 and older who speak English, have mobility issues, low income, and show no signs of cognitive impairment. They must be experiencing sleep or circadian disturbances but not severe untreated sleep apnea or other conditions that severely affect sleep. Participants need to consent to communication between researchers and their medical providers.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive TranS-C+MSI or TranS-C alone in eight 50-minute, weekly, individual sessions
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Memory Support Intervention
- Transdiagnostic Intervention for Sleep and Circadian Dysfunction
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Berkeley
Lead Sponsor